DNLI: Multiplikator Forward P/S Denali Corp
Geopolitical tensions and the decoupling of ties are hindering global medical research, as reflected in the forward P/S dynamics of Denali Therapeutics (DNLI), where the parameter value equals 140.10. Breakthrough developments in crossing the blood-brain barrier via the TV platform are accelerating the creation of Alzheimer's and Parkinson's therapies. Meanwhile, strategic alliances with pharma behemoths and a diversified pipeline significantly mitigate the financial risks for this young biotech.
Rincian metrik lan analitis perusahaan Denali Corp (DNLI)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Denali Therapeutics|DNLI - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Denali Therapeutics|DNLI - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku Denali Corp|DNLI - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Denali Therapeutics|Indikator likuiditas cepet denalitherapeutics.com
- rincian asil keuangan lan kelipatan valuasi:
DNLI - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Denali Therapeutics|DNLI - Periode bali modal bisnis|Pangali Forward P/E Denali Therapeutics Inc|DNLI - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Denali Corp|DNLI - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Denali Therapeutics|DNLI - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan denalitherapeutics.com|DNLI - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Denali Therapeutics
- rincian pendapatan lan dodolan:
Pambiji fundamental:Denali Therapeutics Inc. DNLI
To protect capital from volatility, it is essential for an investor to determine the equilibrium point between the market price and future cash flows. The unique blood-brain barrier crossing platform of Denali Therapeutics (DNLI) creates high added value, which the forward P/S ratio translates into a market capitalization valuation relative to expected revenue, allowing for a precise calibration of the asset's fundamental overheating within a portfolio.
Analisis pesaing
Biogen - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake NBIX (Neurocrine)|Regencell - Multiplikator Forward P/S|Rega forward marang dodolan AXSM (Axsome Corp)|ACAD: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep xenon-pharma.com (XENE)|Rasio rega marang prakiraan pendapatan Viking Therapeutics, Inc.|SUPN: Rega forward marang dodolan|Multiplikator Forward P/S CPRX|Multiplikator Forward P/S Harmony Corp (HRMY)|Rasio rega marang prakiraan pendapatan Biohaven Ltd. BHVN|AMLX (amylyx.com) - Rega mangsa ngarep marang pendapatan|Trevi Therapeutics, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Praxis Precision Medicines Inc|AVXL (Anavex Corp) - Multiplikator forward rega marang pendapatan|CeriBell EEG (CBLL) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan PRTA|ALEC (Alector Therapeutics) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S ANNX|Rasio kapitalisasi marang dodolan sing dikarepake omeros.com|Multiplikator Forward P/S NGNE (Neurogene Corp)|ACIU - Multiplikator forward rega marang pendapatan|VYGR - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake neumoratx.com NMRA|SCLX: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan TVGN|Rasio rega marang prakiraan pendapatan Alpha Cognition Inc|Kapitalisasi marang prakiraan pendapatan CGTX (Cognition Therapeutics Inc.)|Rasio rega marang prakiraan pendapatan Inhibikase Therapeutics (IKT)|Rasio rega marang prakiraan pendapatan SAVA (cassavasciences.com)|Multiplikator Forward P/S ASRT (Assertio)|Rasio kapitalisasi marang dodolan sing dikarepake Coya Therapeutics Inc (COYA)|VTGN - Rasio rega marang prakiraan pendapatan|OVID (Ovid Therapeutics Inc.) - Kapitalisasi marang prakiraan pendapatan|ABOS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep cervomed.com (CRVO)|Multiplikator forward rega marang pendapatan ATHE|Multiplikator Forward P/S Clene Nanomedicine|Rasio rega marang prakiraan pendapatan PepGen Inc. (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Relmada Therapeutics RLMD|annovisbio.com (ANVS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Grace Tx - Multiplikator Forward P/S|AIFF (Firefly Neuroscience, Inc.) - Kapitalisasi marang prakiraan pendapatan|KLTO: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NeuroSense Therapeutics Ltd. (NRSN)|Rasio rega marang prakiraan pendapatan Reviva Pharmaceuticals|Kapitalisasi marang prakiraan pendapatan MTVA (MetaVia, Inc.)|Multiplikator Forward P/S NRXS|Multiplikator Forward P/S heliusmedical.com (HSDT)|Rasio rega marang prakiraan pendapatan Passage Bio PASG|Neuphoria Therapeutics, Inc. - Rasio rega marang prakiraan pendapatan|Minerva Neurosciences - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake athira.com ATHA|ADXN (Addex Therapeutics Ltd) - Multiplikator forward rega marang pendapatan|Alzamend Neuro - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan CYCN|PTIX (Protagenic) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S KTTA|CRGT (cortigent.com) - Rega forward marang dodolan|Multiplikator Forward P/S ATXI (Avenue Therapeutics, Inc.)|Brainstorm Cell Therapeutics Inc. (BCLI) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CARA - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CHRO (Chromocell)|ELYM: Multiplikator Forward P/S|Intra-Cellular Therapies, Inc. (ITCI) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Longboard Pharmaceuticals, Inc.|Marinus Pharmaceuticals Inc - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S NKGN|NRBO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Sage Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S synaptogen.com SNPX|TRVN: Multiplikator forward rega marang pendapatan|Vigil Neuroscience - Rasio rega marang pendapatan sing dikarepake|WENA: Multiplikator Forward P/S|CERE - Rasio kapitalisasi marang dodolan sing dikarepake
